4-butyrolactone has been researched along with sdz 208-912 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsson, A; Ekman, A; Hoffmann, WE; Lum, JT; Piercey, MF; Svensson, K | 1 |
| Coward, DM; Dixon, AK; Enz, A; Karobath, M; Shearman, G; Urwyler, S; White, TG | 1 |
| Baldessarini, RJ; Huston-Lyons, D; Marsh, ER | 1 |
3 other study(ies) available for 4-butyrolactone and sdz 208-912
| Article | Year |
|---|---|
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
Topics: 4-Butyrolactone; Animals; Behavior, Animal; Brain; Dopamine; Dopamine Agents; Ergolines; Lisuride; Male; Motor Activity; Neurons; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Reserpine; Serotonin; Substantia Nigra; Time Factors | 1991 |
Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ 208-911 and SDZ 208-912.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Dopamine; Dopamine Agents; Ergolines; Female; Male; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1990 |
Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.
Topics: 4-Butyrolactone; Animals; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Extrapyramidal Tracts; Hydrazines; Limbic System; Male; Rats; Rats, Sprague-Dawley | 1994 |